1st Quarter - Report

THE PETRIZZO GROUP, INC. for IBIO, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and development of domestic advanced vaccine manufacturing platforms. COVID-19 pandemic preparedness.

LobbyistCovered position, as disclosed
CAMILLE JUDITH LEPIRE Deputy Chief of Staff, Congressman Kevin Brady
MEGAN CRISTINA PEREZ BURKE Legislative Director & Health Policy Director, Congresswoman Cathy McMorris Rodgers
TJ PETRIZZO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and development of domestic advanced vaccine manufacturing platforms. COVID-19 pandemic preparedness.

LobbyistCovered position, as disclosed
CAMILLE JUDITH LEPIRE New —
MEGAN CRISTINA PEREZ BURKE Legislative Director & Director Health Policy, Congresswoman Cathy McMorris Rodgers
TJ PETRIZZO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

FY22 funding for advanced manufacturing technologies that utilize plants.

LobbyistCovered position, as disclosed
CAMILLE JUDITH LEPIRE New —
MEGAN CRISTINA PEREZ BURKE —
TJ PETRIZZO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.